Robotics continued to help fuel growth in orthopedics in Q221 as new products and companies heat up the market and enabling technologies gain momentum across TJR.
Once again, robotics contributed to revenue growth in the orthopedics market in Q221 and competition continues to heat up with several regulatory clearances and other developments from new market entrants in the quarter. Aside from robotics, enabling technology including intra-operative augmented reality, preoperative planning and navigation reached a number of milestones in Q221 across all indications in total joint replacement.
Among the many topics, including company revenues, market shares, charts and expert analysis, covered in the comprehensive Q221 CAS Ortho Market Recap* are: